Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

The Leica ASP6025 Tissue Processor. Pathology and Hematology Departments. The Recalled by Leica Microsystems, Inc. Due to The ASP6025 Tissue Processor instrument is incorrectly getting...

Date: July 27, 2015
Company: Leica Microsystems, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Leica Microsystems, Inc. directly.

Affected Products

The Leica ASP6025 Tissue Processor. Pathology and Hematology Departments. The Leica ASP6025 Tissue Processor is an automated system used to process tissue specimens for examination through fixation, dehydration and infiltration.

Quantity: U.S. Quantity Distributed: 163 systems; Foreign Quantity Diistributed: 410 systems.

Why Was This Recalled?

The ASP6025 Tissue Processor instrument is incorrectly getting into a state of bottle empty during retort filling, after passing the fill lever sensor 2 and prior to reaching level sensor 3, thus not completing a 5 litre fill.

Where Was This Sold?

This product was distributed to 33 states: AZ, AR, CA, CT, FL, GA, HI, ID, IL, IN, IA, KY, LA, MD, MA, MN, MO, MT, NE, NV, NJ, NM, NY, NC, OH, PA, SC, TN, TX, VA, WA, WV, WI

Affected (33 states)Not affected

About Leica Microsystems, Inc.

Leica Microsystems, Inc. has 40 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report